C-reactive protein as an independent marker of prognosis in patients with acute coronary syndrome: Comparison with cardiac troponin T;C-reaktives protein als unabhangiger prognosemarker beim akuten koronarsyndrom im vergleich zu troponin T

Zeitschrift fur Kardiologie

Volumn 89, Issue 8, 2000, Pages 658-666

  Mockel M ^a   Heller Jr , G ^b   Muller C ^a   Klefisch, F R ^a   Riehle, M ^a   Searle, J ^a   Frei, U ^a   Stork T ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c Karl Olga Krankenhaus   (Germany)

Author keywords

Acute coronary syndrome; C reactive protein; Risk assessment; Troponin T

Indexed keywords

C REACTIVE PROTEIN; TROPONIN T; BIOLOGICAL MARKER;

ARTICLE; CAUSE OF DEATH; DEVICE; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; HEART MUSCLE ISCHEMIA; PREDICTION; PROGNOSIS; RECURRENT DISEASE; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; UNSTABLE ANGINA PECTORIS; ACUTE DISEASE; BLOOD; COMPARATIVE STUDY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MALE; MIDDLE AGED; ROC CURVE; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; TIME;

ACUTE DISEASE; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TROPONIN T;

EID: 0034240997     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003920070193     Document Type: Article

References (31)

1. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study
2. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes
3. Comparison of the prognostic value of c-reactive protein and troponin I in patients with unstable angina pectoris
4. Unstable angina. A classification
5. Can C reactive protein or troponins T and I predict outcome in patients with intractable unstable angina?
6. Chronic infections and coronary heart disease: Is there a link?
7. Acute-phase proteins and other systemic responses to inflammation
8. S-troponin T in suspected ischemic myocardial injury compared with mass and catalytic concentrations of S-creatine kinase isoenzyme MB
9. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I
10. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels
11. The prognostic value of serum troponin T in unstable angina
12. For the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Production of C-reactive protein and risk of coronary events in stable and unstable angina
13. Development and in vitro characterization of a new immunoassay of cardiac troponin T
14. Diagnostic efficiency of troponin T measurements in acute myocardial infarction
15. Noninvasive risk stratification in unstable coronary artery disease: Exercise test and biochemical markers. FRISC Study Group
16. Risk stratification in unstable coronary artery disease. Additive value of troponin T determinations and pre-discharge exercise tests. FRISK Study Group
17. Early diagnosis and exclusion of acute myocardial infarction using biochemical monitoring. The BIOMACS Study Group. Biochemicals Markers of Acute Coronary Syndromes
18. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group
19. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group
20. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina
21. Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. TRIM Study Group. Thrombin Inhibition in Myocardial ischemia
22. C reactive protein and its relation to cardiovascular risk factors: A population based cross sectional study
23. Prognostic value of cardiac Troponin T and I elevations in renal disease patients without acute coronary syndromes: A 9-month outcome analysis
24. Troponin T in patients with low grade or atypical angina. Identification of a high risk group for short- and long-term cardiovascular events
25. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: A TIMI 11A substudy. Thrombolysis in Myocardial Infarction
26. Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators
27. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators
28. Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris
29. Inflammation, Aspirin, and the risk of cardiovascular disease in apparently healthy men
30. Atherosclerosis - An inflammatory disease
31. For the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris